CA
QNTM

Clearstead Advisors’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Clearstead Advisors’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3
Closed – – 1310
2021
Q1 		$0 Buy
+3
New +$419 ﹤0.01% 1193

Other funds holding QNTM

IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RPC
Rossmore Private Capital Glastonbury, Connecticut $1.14B AUM 23.53% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Clearstead Advisors's QNTM Position: Q2 2021 in Review

Clearstead Advisors sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q2 2021, closing a stake of 3 shares.

Clearstead Advisors first reported a position in QNTM in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 17 funds tracked by Wall St. Rank hold QNTM as of Q2 2021.

  • Clearstead Advisors reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q2 2021 after selling out during the quarter.
  • Clearstead Advisors sold 3 Quantum Biopharma Class B Subordinate Voting Shares shares in Q2 2021.
  • Clearstead Advisors first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2021 and held it in 1 quarter.
  • Clearstead Advisors's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $0 in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q2 2021.

Based on Clearstead Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.